TY - JOUR
T1 - Adverse effects from selected antidotes commonly used in poisonings
AU - Høgberg, Lotte Christine Groth
AU - Bøgevig, Søren
PY - 2021
Y1 - 2021
N2 - The number of specific antidotes available is low compared to the wide range of substances, of natural or synthetic origin, able to produce toxic symptoms in the human body. Some of these antidotes being very specific in target and effect, e.g., antagonism at the μ-opioid receptors by naloxone in an opioid overdose, other antidotes being unspecific, e.g., glucagon or atropine in the case of betablocker poisoning or activated charcoal with its ability reduce absorption of a wide range of toxic substances. In the following, we present four important antidotes (N-acetylcysteine, deferoxamine, methylene blue and physostigmine) and focus on some of their reported potentially severe adverse effects.
AB - The number of specific antidotes available is low compared to the wide range of substances, of natural or synthetic origin, able to produce toxic symptoms in the human body. Some of these antidotes being very specific in target and effect, e.g., antagonism at the μ-opioid receptors by naloxone in an opioid overdose, other antidotes being unspecific, e.g., glucagon or atropine in the case of betablocker poisoning or activated charcoal with its ability reduce absorption of a wide range of toxic substances. In the following, we present four important antidotes (N-acetylcysteine, deferoxamine, methylene blue and physostigmine) and focus on some of their reported potentially severe adverse effects.
UR - http://www.scopus.com/inward/record.url?scp=85130496637&partnerID=8YFLogxK
U2 - 10.1097/FAD.0000000000000054
DO - 10.1097/FAD.0000000000000054
M3 - Journal article
SN - 0044-6394
VL - 327
SP - 1267
EP - 1270
JO - Adverse Drug Reaction Bulletin
JF - Adverse Drug Reaction Bulletin
ER -